Randomised, placebo-controlled, relapse-prevention study with once-daily quetiapine sustained release in patients with schizophrenia

被引：0
|
作者：
Peuskens, J.
Trivedi, J. K.
Malyarov, S.
Brecher, M.
Svensson, O.
Miller, F.
Persson, I.
Meulien, D.
机构：
[1] Univ Psychiat Centrum KU Leuven, Kortenberg, Belgium
[2] King George Med Univ, Lucknow, Uttar Pradesh, India
[3] Kyiv Psychoneurol Hosp, Kiev, Ukraine
[4] AstraZeneca, Wilmington, DE USA
[5] AstraZeneca R&D, Sodertalje, Sweden
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [31] Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone
    J Pool
    P Kaihlanen
    G Lewis
    D Ginsberg
    S Oparil
    R Glazer
    FH Messerli
    Journal of Human Hypertension, 2001, 15 : 495 - 498
  • [32] Once-daily treatment of patients with hypertension:: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone
    Pool, J
    Kaihlanen, P
    Lewis, G
    Ginsberg, D
    Oparil, S
    Glazer, R
    Messerli, FH
    JOURNAL OF HUMAN HYPERTENSION, 2001, 15 (07) : 495 - 498
  • [33] MULTICENTER, PLACEBO-CONTROLLED STUDY OF CABERGOLINE TAKEN ONCE-DAILY IN THE TREATMENT OF PARKINSONS-DISEASE
    HUTTON, JT
    HURTIG, H
    HINER, B
    KOLLER, W
    LIEBERMAN, A
    AHLSKOG, J
    PFEIFFER, R
    RODNITZKY, R
    WATERS, C
    MUENTER, M
    NEUROLOGY, 1995, 45 (04) : A203 - A203
  • [34] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A NEW, ONCE-DAILY, SLOW-RELEASE, THEOPHYLLINE CAPSULE PREPARATION IN ASTHMA
    ALWAZIR, YA
    WILLIAMS, PE
    CAMPBELL, IA
    ROUTLEDGE, PA
    MEDICAL SCIENCE RESEARCH-BIOCHEMISTRY, 1987, 15 (1-2): : 9 - 10
  • [35] Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: A placebo-controlled 26-week study
    Pigott, TA
    Carson, WH
    Saha, AR
    Torbeyns, AF
    Stock, EG
    Ingenito, GG
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) : 1048 - 1056
  • [36] Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
    Kornmann, O.
    Dahl, R.
    Centanni, S.
    Dogra, A.
    Owen, R.
    Lassen, C.
    Kramer, B.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 273 - 279
  • [37] Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: A double blind placebo-controlled and randomised study
    Safarineiad, M. R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 144 - 144
  • [38] EFFICACY AND SAFETY OF ONCE-DAILY INHALED UMECLIDINIUM IN ASIAN PATIENTS WITH COPD: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Zheng, Jinping
    Huang, Chunchen
    Luo, Xian
    Du, Xin
    RESPIROLOGY, 2018, 23 : 133 - 133
  • [39] 24-HOUR EFFICACY OF 2 DOSE LEVELS OF A ONCE-DAILY SUSTAINED-RELEASE DILTIAZEM FORMULATION IN STABLE ANGINA - A PLACEBO-CONTROLLED TRIAL
    FRANCES, Y
    GAGEY, S
    STALLABOURDILLON, A
    BADOURALY, A
    BENKEMOUN, P
    BINEAU, P
    BOUSSER, JP
    CHABANIER, A
    CHAMPOUD, O
    CHARLIAGUET, JP
    DRAWIN, T
    DUMOULIN, P
    FRAISSE, A
    GAUDEUL, P
    GINESTES, J
    HENRY, M
    LARDOUX, H
    MARTIN, M
    MORALY, JP
    ROUFFAUD, J
    SARDA, R
    TARDIEU, A
    YVENOU, L
    BAUERLEIN, G
    KIKIS, D
    SENGES, J
    DEDEVITIS, O
    TRIMARCO, B
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (03) : 277 - 282
  • [40] Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study
    Zhong, Nanshan
    Zheng, Jinping
    Lee, Sang Haak
    Lipson, David A.
    Du, Xin
    Wu, Shunquan
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 809 - 819
12345